Literature DB >> 24030034

Somatic cell transformation into stem cell-like cells induced by different microenvironments.

Jeong Mook Lim1, Seung Pyo Gong2.   

Abstract

Development of induced pluripotent stem cell (iPSC) technology introduced a novel way to derive pluripotent stem cells, but the genetic manipulation required to generate iPSCs may lead to uncontrolled tumorigenesis of the established cells and thus limit clinical feasibility of the technology. Numerous attempts have been made to date, and alternative reprogramming of somatic cells to reactivate cellular plasticity after differentiation has been suggested. As a result, it had become clear that cell-to-cell interactions and specific acellular environments can be utilized for somatic cell reprogramming. In our previous studies, embryonic stem cell (ESC)-like cells could be derived from transforming ovarian cells and fetal fibroblasts by cell-to-cell interaction or specific cell-mediated microenvironmental factor(s). This cellular event was induced without undertaking genetic manipulation of progenitor cells. Several differences were found between the cellular properties of niche-induced, ESC-like cells and those of genetically manipulated iPSCs and the referenced ESCs. Thus, we provided evidence that terminally differentiated somatic cells either acquire pluripotency-like activity or possess cellular and genetic plasticity under a specific microenvironment and/or cell-to-cell interaction. In this minireview, we discuss derivation of stem cell-like cells under specific microenvironmental conditions in terms of technical perspectives and limitations.

Keywords:  genetic plasticity; immune-specific; microenvironment; pluripotency; somatic cell; transformation

Mesh:

Year:  2013        PMID: 24030034      PMCID: PMC3903693          DOI: 10.4161/org.26202

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  29 in total

1.  Transformation of somatic cells into stem cell-like cells under a stromal niche.

Authors:  Seung Tae Lee; Seung Pyo Gong; Kyung Eun Yum; Eun Ju Lee; Chae Hyun Lee; Jun Hee Choi; Dae Yong Kim; Hojae Han; Kye-Seong Kim; Eriona Hysolli; Ji Yeon Ahn; In-Hyun Park; Jae Yong Han; Jae-Wook Jeong; Jeong Mook Lim
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

2.  Expression of Snail protein in tumor-stroma interface.

Authors:  C Francí; M Takkunen; N Dave; F Alameda; S Gómez; R Rodríguez; M Escrivà; B Montserrat-Sentís; T Baró; M Garrido; F Bonilla; I Virtanen; A García de Herreros
Journal:  Oncogene       Date:  2006-03-27       Impact factor: 9.867

Review 3.  Connective tissue growth factor in the ovarian paracrine system.

Authors:  C R Harlow; Stephen G Hillier
Journal:  Mol Cell Endocrinol       Date:  2002-02-22       Impact factor: 4.102

4.  Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3.

Authors:  Seung Tae Lee; Jung Im Yun; Andre J van der Vlies; Stephan Kontos; Mi Jang; Seung Pyo Gong; Dae Yong Kim; Jeong M Lim; Jeffrey A Hubbell
Journal:  Biomaterials       Date:  2012-09-19       Impact factor: 12.479

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

6.  Human embryonic stem cells derived by somatic cell nuclear transfer.

Authors:  Masahito Tachibana; Paula Amato; Michelle Sparman; Nuria Marti Gutierrez; Rebecca Tippner-Hedges; Hong Ma; Eunju Kang; Alimujiang Fulati; Hyo-Sang Lee; Hathaitip Sritanaudomchai; Keith Masterson; Janine Larson; Deborah Eaton; Karen Sadler-Fredd; David Battaglia; David Lee; Diana Wu; Jeffrey Jensen; Phillip Patton; Sumita Gokhale; Richard L Stouffer; Don Wolf; Shoukhrat Mitalipov
Journal:  Cell       Date:  2013-05-15       Impact factor: 41.582

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Generation of mouse induced pluripotent stem cells without viral vectors.

Authors:  Keisuke Okita; Masato Nakagawa; Hong Hyenjong; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Science       Date:  2008-10-09       Impact factor: 47.728

9.  Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.

Authors:  Qiuhui Pan; Yongchun Yu; Qiongyu Chen; Chunsheng Li; Hong Wu; Yang Wan; Ji Ma; Fenyong Sun
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

10.  Virus-free induction of pluripotency and subsequent excision of reprogramming factors.

Authors:  Keisuke Kaji; Katherine Norrby; Agnieszka Paca; Maria Mileikovsky; Paria Mohseni; Knut Woltjen
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  2 in total

1.  Healing of bone defects by induced pluripotent stem cell-derived bone marrow mesenchymal stem cells seeded on hydroxyapatite-zirconia.

Authors:  Lishen Zhou; Renfu Quan; Jun Yang; Hong Xu
Journal:  Ann Transl Med       Date:  2021-12

Review 2.  A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.

Authors:  Pallavi Pushp; Diogo E S Nogueira; Carlos A V Rodrigues; Frederico C Ferreira; Joaquim M S Cabral; Mukesh Kumar Gupta
Journal:  Stem Cell Rev Rep       Date:  2020-10-23       Impact factor: 5.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.